论文部分内容阅读
为期3个月的随机开放试验,48例2型糖尿病(T2DM)患者随机分为诺和笔4组(24例)与诺和笔3组(24例),比较注射的准确性与依从性。结果:诺和笔4组在注射准确性与依从性方面都优于诺和笔3组,具有显著性差异(P<0.05)。结论:诺和笔4比诺和笔3在注射胰岛素治疗糖尿病时具有更佳的疗效,诺和笔4比诺和笔3更易学易用,患者更易接受。
A three-month randomized open-label trial of 48 patients with type 2 diabetes mellitus (T2DM) was randomized into 4 groups (24 patients) and Novo-pen 3 group (24 patients). The accuracy and compliance of injection were compared. Results: Novo pen 4 group was superior to Novo-pen three groups in injection accuracy and compliance, with significant difference (P <0.05). CONCLUSIONS: Novo Pen 4 and Novo 3 have better efficacy in the treatment of diabetes mellitus with insulin injection. Novo Pen 4 and Pen 3 are easier to learn and use, and patients are more receptive.